Other languages Integral Diagnostics Limited

Equities

IDX

AU000000IDX2

Market Closed - Australian S.E. Other stock markets 02:10:12 2024-05-03 EDT			5-day change	1st Jan Change
2.45 ^AUD	+0.82%		-0.81%	+28.61%

03-06	Morgan Stanley Adjusts Integral Diagnostics’ Price Target to AU$1.85 From AU$1.70, Keeps at Underweight	MT
02-21	Jarden Research Adjusts Integral Diagnostics’ Price Target to AU$2.59 From AU$2.54, Keeps at Neutral	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integral Diagnostics Shares Gain 2%; Posts 7% Rise in H1 FY24 Revenue, Profit Slips	02-19
Integral Diagnostics Reports H1 FY24 Revenue Up 7% to AU$231.3 Million; EPS of AU$0.031	02-19
Integral Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-19
Integral Diagnostics Limited Announces Change of Company Secretary	12-11
Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023	11-29
4DMedical Enters Agreement with Integral Diagnostics for XV Technology Distribution; Shares Jump 9%	23-10-29
Integral Diagnostics Announces Release of Certain Shares from Voluntary Escrow	23-10-10
Integral Diagnostics Appoints Chair Elect	23-09-28
Integral Diagnostics Limited Appoints Toby Hall as Director	23-09-27
Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023	23-09-25
Integral Diagnostics Raises Final Dividend as Fiscal 2023 Profit Rises	23-08-27
Integral Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27
Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023	23-08-27
Integral Diagnostics Limited Announces Board Changes	23-08-09
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow	23-08-07
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow in July	23-06-20
Integral Diagnostics Grows Fiscal H1 Profit, Lowers Interim Dividend; Shares Down 16%	23-02-16
Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023	23-02-16
Integral Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-16
Integral Diagnostics Terminates Exact Radiology Takeover Deal	22-10-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Integral Diagnostics Limited

Equities

IDX

AU000000IDX2

Other languages

Filters